by Benzinga Insights | Aug 31, 2026 | General
Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 22.44% on an annualized basis producing an average annual return of 33.55%. Currently, Cogent Biosciences has a market capitalization of $6.12 billion. Buying $100 In COGT: If an...
by Benzinga Insights | Aug 31, 2026 | General
Enpro (NYSE:NPO) has outperformed the market over the past 15 years by 1.79% on an annualized basis producing an average annual return of 15.14%. Currently, Enpro has a market capitalization of $6.26 billion. Buying $100 In NPO: If an investor had bought $100 of NPO...
by Benzinga Insights | Aug 31, 2026 | General
Herc Holdings (NYSE:HRI) has outperformed the market over the past 10 years by 2.55% on an annualized basis producing an average annual return of 15.9%. Currently, Herc Holdings has a market capitalization of $5.09 billion. Buying $100 In HRI: If an investor had...
by Benzinga Insights | Aug 31, 2026 | General
CACI International (NYSE:CACI) has outperformed the market over the past 10 years by 6.63% on an annualized basis producing an average annual return of 19.98%. Currently, CACI International has a market capitalization of $13.76 billion. Buying $1000 In CACI: If an...
by Benzinga Insights | Aug 31, 2026 | General
Allstate (NYSE:ALL) has outperformed the market over the past 15 years by 3.61% on an annualized basis producing an average annual return of 16.97%. Currently, Allstate has a market capitalization of $66.36 billion. Buying $100 In ALL: If an investor had bought $100...
Recent Comments